UCD Professor commended for ‘exceptional contribution’ in pandemic by IRC

The Irish Research Council today announced its 2021 Researcher of the Year awards.

Researcher of the year is Yvonne Buckley. She is Professor of Zoology at Trinity College Dublin. She got it because of the work focussing on the growth by IRC, reproduction and survival of plant and animal species.

UCD Chair of Critical Care Medicine, Professor Alistair Nichol received a special commendation. It was for his ‘exceptional contribution’ in the field of medical research. Specifically in critical care clinical trials and especially in the global fight against the COVID-19 pandemic.

On receiving the accolade, Professor Nichol spoke out. “I am honoured that the IRC has recognised my work and that of my team over the last decade and particularly during the COVID pandemic, with their special commendation today. This represents many years’ work by a large team in Ireland and beyond. I am very grateful to my colleagues within UCD, the Irish Critical Care Community and our global network collaborators.

“Ireland’s Intensive Care Units continue to be the front line in our ongoing war against COVID. Our research collaborations have allowed us to understand the COVID waves during the pandemic. Therefore allowing us clinicians to identify patients at the highest risk of death, and the genetic factors associated with death in the ICU. This is so we can identify novel therapies.

Professor Nichol is Director of the Irish Critical Care-Clinical Trials Network (ICC-CTN). It runs and builds capacity for running, clinical trials in Irish Intensive Care Units (ICUs). Funded by the Health Research Board, the ICC-CTN has also become a world-leading coordination centre. It was for major global clinical trials, including REMAP-CAP.

IRC

What is REMAP?

REMAP (Randomised, Embedded, Multifactorial, Adaptive Platform trial) is a global trial that determines and continuously updates the optimal set of treatments. This is for community-acquired pneumonia. REMAP-CAP has added trial domains so that the platform can respond rapidly to COVID-19, specifically (i) antiviral therapy and (ii) immune modulation therapy.

To date, REMAP-CAP has identified three safe, effective treatments that reduce death and organ failure in critically ill COVID patients. This is namely steroids, IL6 receptor antagonists and anticoagulation, in ward patients.

It has also determined that Hydroxychloroquine, Keletra, Hydroxychloroquine and Keletra in combination, convalescent plasma, Anakinra and anticoagulation do not improve outcomes in critically ill patients with COVID-19.

“Our global trial (REMAP-CAP) has already identified three highly effective and safe treatments. They reduce death and organ failure in critically ill COVID patients and, equally important, six treatments that don’t improve outcomes. In addition, we are examining the effectiveness of another 10 treatments in COVID. In addition to this we are preparing for influenza, both seasonal and future pandemic. These findings help to save lives, continually optimize care of ICU patients with COVID. Therefore it gives a pathway forward out of the crisis facing our hospitals,” Professor Nichol said.

Professor Nichol’s team continue to address important evidence gaps. For instance whether or not Ivermectin improves outcomes in critically ill COVID patients. The Irish arm of this trial has started in St Vincent’s University Hospital last week.

In Ireland, hospitals confirmed 545 COVID cases (2 December 2021). In addition to 117 in ICU, with six admitted to ICU in the last 24 hours and two discharged from ICU.

Director of the IRC spoke out on the announcement of the awards.

Peter Brown said: “I would like to congratulate the awardees on their awards. The standard of nominations this year was extremely high. Each of the winners should be immensely proud of their achievements. It is great to see this year’s winners representing a diverse range of research interests, which reflects the creativity and dynamism of the research community here in Ireland. The IRC is equally proud to have supported the development of the work of these researchers through our funding.

“This year’s winners demonstrate how research helps society answer some of the big questions of our time. It can make a significant and lasting impact. We look forward to continuing to cultivate a vibrant research community in which there are world-class researchers across disciplines.”

UCD’s Professor of Social Policy Michelle Norris was awarded the Impact Award for her proven record of research impact ‘beyond academia’ in the field of social housing policy.

Postdoctoral researcher in the School of Psychology and Institute of Neuroscience at Trinity College Dublin is Dr Kathy Ruddy. She won the ‘Early Career Researcher of the Year’ award for her work using brain-computer interfaces to improve brain function.

Postdoctoral researcher Dr Sara Delmedico, UCD School of Languages, Cultures and Linguistics, was awarded the IRC Maurice J Bric Medal of Excellence, as the top-ranked Postdoctoral Fellow of Arts, Humanities and Social Sciences under the Council’s 2021 Government of Ireland funding programme.

Postdoctoral researcher Dr Marco Timpanella, UCD School of Mathematics and Statistics, was awarded the IRC Thomas Mitchell Medal of Excellence, as the top-ranked Postdoctoral Fellow in the domain of Science, Technology, Engineering and Mathematics (STEM) in the Government of Ireland scheme.

To learn more about all of the awardees see: https://research.ie/news/

Read our LATEST NEWS

 

Leave a Reply

Your email address will not be published.

Please Confirm

This website is only for the eyes of medical professionals. Are you a medical professional?